Genelux (GNLX) Change in Cash (2022 - 2026)
Genelux's (GNLX) quarterly Change in Cash came in at $3.9 million in Q1 2026, down 48.44% year-on-year from $7.6 million in Q1 2025, and up 514.66% quarter-over-quarter from $641000.0 in Q4 2025.
Genelux (GNLX) Change in Cash (2022 - 2026) Analysis & Trends
Genelux's Change in Cash history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Change in Cash fell 48.44% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was -$6.9 million, a 157.09% decrease from a year earlier, with the FY2025 full-year figure at -$3.2 million, down 278.9% from the prior year.
- Change in Cash climbed to $3.9 million in Q1 2026 per GNLX's latest filing, from $641000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $16.8 million in Q2 2023 and bottomed at -$20.5 million in Q4 2023.
- The 5-year median for Change in Cash is $2.5 million (2024), against an average of $705533.3.
- Biggest YoY gain for Change in Cash was 270.93% in 2023; the steepest drop was 2001.85% in 2023.
- Year by year, Change in Cash stood at -$973000.0 in 2022, then slumped by 2001.85% to -$20.5 million in 2023, then surged by 112.04% to $2.5 million in 2024, then tumbled by 73.97% to $641000.0 in 2025, then jumped by 514.66% to $3.9 million in 2026.
- Per Business Quant, the three latest GNLX Change in Cash figures stand at $3.9 million (Q1 2026), $641000.0 (Q4 2025), and -$1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 641,000.00 |
| Sep 30, 2025 | -1.85 Mn |
| Jun 30, 2025 | -9.66 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | -5.36 Mn |
| Dec 31, 2023 | -20.45 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 16.80 Mn |
| Mar 31, 2023 | 9.94 Mn |
| Dec 31, 2022 | -973,000.00 |
| Mar 31, 2022 | 2.68 Mn |